Lagos clarifies HIV data, procures ARVs
Analysis based on 25 articles · First reported Jun 29, 2026 · Last updated Jul 08, 2026
The clarification may reduce panic and stigma, supporting continued HIV testing and treatment uptake. The direct procurement of ARVs by Nigeria — Lagos State could reduce dependence on donor funding and strengthen the local pharmaceutical supply chain, potentially benefiting healthcare and pharmaceutical sectors.
The Nigeria — Lagos State Government has dismissed reports that it recorded 10,430 new HIV infections in 2025, clarifying that the figure represents newly diagnosed cases, not new infections. The clarification came after a federal report ranked Lagos highest in new HIV infections. Nigeria — Lagos State AIDS Control Agency (LSACA) CEO Dr. Folakemi Animashaun explained that stronger surveillance and expanded testing lead to higher case detection. She presented data showing declining positivity rates (2.4% in 2025, 1.9% in Q1 2026) and high viral suppression (97%). Lagos also announced it will directly procure antiretroviral drugs, becoming the first sub-national government in Nigeria to do so, with the first batch expected by August 2026. The state is exploring local production with UNAIDS and learning from Kenya.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard